Salem-based regenerative medicine startup, is working towards its final FDA safety study needed to begin clinical trials.

Privacy professionals are facing a data-dominated landscape, a complex web of regulations and more limited resources this year. According to the State of Privacy 2026 survey report from ISACA, these ...

Shovelling snow has been linked with increased rates of back problems, bone fractures and even heart attacks, with studies ...

Moscow agrees with U.S. President Donald Trump ’s view that Ukraine is holding up a peace deal to end the almost four years ...

Mattel recently released an autistic Barbie, and transphobes are freaking out about the doll “promoting gender identity” ...

In recent Trevor Project polling, 90% of LGBTQ+ youth said recent politics negatively impacted their well-being, and nearly ...

Indiana’s cities and towns would have the option of moving their elections to even-numbered years under a bill advancing in ...

Every Saturday in São Paulo, a quiet yet meaningful rhythm takes shape in the Armenian community. From youth football (soccer ...

A pivotal meeting between Canadian Prime Minister Mark Carney and Chinese leader Xi Jinping is happening in Beijing shortly ...

Avalon Advanced Materials Inc. (TSX: AVL) (OTCQB: AVLNF) ("Avalon" or the "Company") is pleased to announce the commissioning of a new Preliminary Economic Assessment ("PEA") for its Nechalacho Rare ...

CD38 monoclonal antibody; binds to unique CD38 epitopeAMR is a leading cause of kidney transplant loss with no approved ...

The United States on Thursday said Iran halted 800 executions of protesters under pressure from President Donald Trump, after ...